Literature DB >> 21663787

Democracy derived? New trajectories in pluripotent stem cell research.

Christopher Thomas Scott1, Jennifer B McCormick, Mindy C DeRouen, Jason Owen-Smith.   

Abstract

How has the development of human induced pluripotent stem cells (hiPSCs) modified the trajectory of stem cell research? Here, coauthorship networks of stem cell research articles and analysis of cell lines used in stem cell research indicate that hiPSCs are not replacing human embryonic stem cells, but instead, the two cell types are complementary, interdependent research tools. Thus, we conclude that a ban on funding for embryonic stem cell research could have unexpected negative ramifications on the nascent field of hiPSCs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21663787      PMCID: PMC3933363          DOI: 10.1016/j.cell.2011.05.032

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  12 in total

1.  Federal policy and the use of pluripotent stem cells.

Authors:  Christopher Thomas Scott; Jennifer B McCormick; Mindy C Derouen; Jason Owen-Smith
Journal:  Nat Methods       Date:  2010-11       Impact factor: 28.547

2.  Tracking and assessing the rise of state-funded stem cell research.

Authors:  Ruchir N Karmali; Natalie M Jones; Aaron D Levine
Journal:  Nat Biotechnol       Date:  2010-12       Impact factor: 54.908

3.  An international gap in human ES cell research.

Authors:  Jason Owen-Smith; Jennifer McCormick
Journal:  Nat Biotechnol       Date:  2006-04       Impact factor: 54.908

4.  And then there were two: use of hESC lines.

Authors:  Christopher Thomas Scott; Jennifer B McCormick; Jason Owen-Smith
Journal:  Nat Biotechnol       Date:  2009-08       Impact factor: 54.908

5.  Stem cells. Reprogrammed cells come up short, for now.

Authors:  Gretchen Vogel
Journal:  Science       Date:  2010-03-05       Impact factor: 47.728

6.  Stem cells: The dark side of induced pluripotency.

Authors:  Martin F Pera
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

7.  Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.

Authors:  Qiang Feng; Shi-Jiang Lu; Irina Klimanskaya; Ignatius Gomes; Dohoon Kim; Young Chung; George R Honig; Kwang-Soo Kim; Robert Lanza
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

8.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

9.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

10.  The structure of scientific collaboration networks.

Authors:  M E Newman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

View more
  11 in total

1.  Access to human embryonic stem cell lines.

Authors:  Aaron D Levine
Journal:  Nat Biotechnol       Date:  2011-12-08       Impact factor: 54.908

2.  Impedance of novel therapeutic technologies: the case of stem cells.

Authors:  David G Zacharias; Timothy J Nelson; Paul S Mueller; C Christopher Hook
Journal:  Clin Transl Sci       Date:  2012-06-28       Impact factor: 4.689

Review 3.  The race is on: human embryonic stem cell research goes global.

Authors:  Mindy C DeRouen; Jennifer B McCormick; Jason Owen-Smith; Christopher Thomas Scott
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

Review 4.  De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications.

Authors:  Robert L Katona
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

5.  Expand and regularize federal funding for human pluripotent stem cell research.

Authors:  Jason Owen-Smith; Christopher Thomas Scott; Jennifer B McCormick
Journal:  J Policy Anal Manage       Date:  2012

6.  Promoting public trust: ESCROs won't fix the problem of stem cell tourism.

Authors:  Zubin Master; David B Resnik
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

7.  Scope and impact of international research in human pluripotent stem cells.

Authors:  Peter Löser; Sabine Kobold; Anke Guhr; Franz-Josef Müller; Andreas Kurtz
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

Review 8.  Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies.

Authors:  Marinka Brouwer; Huiqing Zhou; Nael Nadif Kasri
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

9.  Cross-disciplinary evolution of the genomics revolution.

Authors:  Alexander M Petersen; Dinesh Majeti; Kyeongan Kwon; Mohammed E Ahmed; Ioannis Pavlidis
Journal:  Sci Adv       Date:  2018-08-15       Impact factor: 14.136

10.  Power-laws and the use of pluripotent stem cell lines.

Authors:  Bernhard M Schuldt; Anke Guhr; Michael Lenz; Sabine Kobold; Ben D MacArthur; Andreas Schuppert; Peter Löser; Franz-Josef Müller
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.